1. Gallegos-Arreola, Martha Patricia, Zúñiga-González, Guillermo M, Figuera, Luis E, Gómez-Meda, Belinda Claudia, Rosales-Reynoso, Mónica Alejandra. 2022. ESR2 gene variants (rs1256049, rs4986938, and rs1256030) and their association with breast cancer risk. In PeerJ, 10, e13379. doi:10.7717/peerj.13379. https://pubmed.ncbi.nlm.nih.gov/35573183/
2. Szaflik, Tomasz, Smolarz, Beata, Mroczkowska, Beata, Forma, Ewa, SzyŁŁo, Krzysztof. . An Analysis of ESR2 and CYP19A1 Gene Expression Levels in Women With Endometriosis. In In vivo (Athens, Greece), 34, 1765-1771. doi:10.21873/invivo.11970. https://pubmed.ncbi.nlm.nih.gov/32606145/
3. Ulhaq, Zulvikar Syambani, Garcia, Cristian Peinado. 2020. Estrogen receptor beta (ESR2) gene polymorphism and susceptibility to dementia. In Acta neurologica Belgica, 121, 1281-1293. doi:10.1007/s13760-020-01360-z. https://pubmed.ncbi.nlm.nih.gov/32335869/
4. Chang, Xueliang, Wang, Hu, Yang, Zhan, Li, Jingdong, Han, Zhenwei. . ESR2 polymorphisms on prostate cancer risk: A systematic review and meta-analysis. In Medicine, 102, e33937. doi:10.1097/MD.0000000000033937. https://pubmed.ncbi.nlm.nih.gov/37335680/
5. Łukasik, Adriana, Kozicka, Karolina, Pisarek, Aleksandra, Wojas-Pelc, Anna. 2021. The role of CYP19A1 and ESR2 gene polymorphisms in female androgenetic alopecia in the Polish population. In Postepy dermatologii i alergologii, 39, 708-713. doi:10.5114/ada.2021.108429. https://pubmed.ncbi.nlm.nih.gov/36090736/